Asia's Premier Event Facilitating End to End AI & Digital Transformation In BioPharma
The Digitalisation and Al presence in the Global Biopharma Industry is valued at approximately USD 1784.1 Million in 2022 and is expected to exhibit a robust growth rate exceeding 5.7% 2023 to 2030. It is expected to reach $2.47 Billion by 2027.
Meanwhile, the APAC market is catching up rapidly with digitalisation as many corporates are adopting technology in their research, manufacturing and supply chain initiatives. Governments including the nations of Singapore, China, Australia, South Korea, Japan, India, Taiwan to mention a few, offer strategic incentives for biomanufacturing, promoting investment, technology adoption infrastructure development and supportive regulations to bolster the region's biopharmaceutical manufacturing capabilities.
The event this year hence features a focused track on Biologics Digitalisation & AI on the first day, 10th of September. This congregation would be a platform to meet the leaders from the Biologics World of APAC, who have pioneered in adopting AI & Digitalisation in the R&D, Manufacturing/Bioprocessing, Quality, Compliance and Supply Chain aspects to improve the efficiency of processes, productivity and to reduce cost while bringing best in quality.
Late Kate
(until 10th September)
*END-USER PRICING IS APPLICABLE to :
Company Profiles: APAC Contract Manufacturing Companies, Biopharma, BIG Pharmas, APAC Academic & Research Institutes.
Job Profiles: Manufacturing, Bioprocessing, Production, USP, DSP, Operations, Site Heads, Drug Substance and Product Manufacturing, Process Development, Quality, Analytics and other related technical designations.
Late Kate
(until 10th September)
*SOLUTION PROVIDER PRICING IS APPLICABLE to
Company Profile: Technology and Solutions Provider, Asian/International Biopharma, BIG Pharmas, CMO’s, Asian Academic/Research Institutes.
Job Profiles: Business Development, Marketing & Sales
Late Kate
(until 10th September)
*END-USER PRICING IS APPLICABLE to :
Company Profiles: APAC Contract Manufacturing Companies, Biopharma, BIG Pharmas, APAC Academic & Research Institutes.
Job Profiles: Manufacturing, Bioprocessing, Production, USP, DSP, Operations, Site Heads, Drug Substance and Product Manufacturing, Process Development, Quality, Analytics and other related technical designations.
Late Kate
(until 10th September)
*SOLUTION PROVIDER PRICING IS APPLICABLE to
Company Profile: Technology and Solutions Provider, Asian/International Biopharma, BIG Pharmas, CMO’s, Asian Academic/Research Institutes.
Job Profiles: Business Development, Marketing & Sales
The Poster Presentation Session at the prestigious 3rd Biologics Contract Manufacturing Asia 2024 in conjunction with Biologics Digitalisation World Asia 2024 conference provides pioneers in the field of biologics with a paramount platform for showcasing groundbreaking research, fostering collaboration, and advancing the frontier of biologics contract manufacturing & digitalisation in the dynamic Asian region.
The session promises to be a vibrant hub of knowledge exchange, where visionaries from diverse backgrounds converge to share their latest findings, innovative methodologies, and cutting-edge solutions. Whether you're an academic scholar or an industry expert, this is your opportunity to shine a spotlight on your work, gain valuable insights, and forge meaningful connections within the thriving biologics community.
Showcase your groundbreaking achievements to more than 600+ attendees that will be present at the conference.
Download the Event Brochure Now!
IMAPAC is the go-to holistic producer of live events, biopharma data and digital marketing solutions for the global biopharmaceutical industry.
© 2024 Imapac. All rights reserved. Trade marks are owned by or licensed to imapac.
Asia's Premier Event Facilitating End to End AI & Digital Transformation In BioPharma